wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36962682-4E6F1974-0EE5-438F-9353-D3FAC2AC7416
Q36962682-4E6F1974-0EE5-438F-9353-D3FAC2AC7416
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36962682-4E6F1974-0EE5-438F-9353-D3FAC2AC7416
Imatinib disrupts lymphoma angiogenesis by targeting vascular pericytes.
P2860
Q36962682-4E6F1974-0EE5-438F-9353-D3FAC2AC7416
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36962682-4E6F1974-0EE5-438F-9353-D3FAC2AC7416
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6de380ebd1d5930128c0e299f9a20b984af9c0fd
P2860
A phase II trial of single agent bevacizumab in patients with relapsed, aggressive non-Hodgkin lymphoma: Southwest oncology group study S0108.